We're pioneering a new class of product candidates based on the revelation that complicated multifactorial diseases, where numerous cellular networks are involved, require multifunctional treatments.
Our innovative paradigm integrates preclinical studies and human data from IRB-approved studies* in a rapid, iterative process to generate candidates with a higher probability of success in less than a year from indication selection.
*Studies conducted under food and dietary supplement guidelines
Designed Amino Acid Compositions (DAAC): Rationally designed product candidates that leverage the diversity and synergy of amino acid biology and are intended to restore health across a network of dysregulated pathways.
